- Home
- PAC vs ASND Comparison
PAC vs ASND Comparison
Compare PAC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAC | ASND |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Mexico | Denmark |
| Employees | 3637 | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 14.7B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | PAC | ASND |
|---|---|---|
| Price | $246.24 | $238.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 16 |
| Target Price | $270.00 | ★ $281.50 |
| AVG Volume (30 Days) | 103.6K | ★ 709.5K |
| Earning Date | 04-20-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $38.79 | $96.35 |
| Revenue Next Year | $8.96 | $44.91 |
| P/E Ratio | $27.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $206.91 | $153.49 |
| 52 Week High | $300.41 | $250.74 |
Technical Indicators
Market Signals| Indicator | PAC | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 48.43 | 52.98 |
| Support Level | $227.66 | $215.18 |
| Resistance Level | $255.55 | $245.88 |
| Average True Range (ATR) | 7.12 | 9.89 |
| MACD | -0.86 | 0.63 |
| Stochastic Oscillator | 53.98 | 61.26 |
Price Performance
Historical ComparisonAbout PAC Grupo Aeroportuario Del Pacifico
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the operation, maintenance, and development of 12 international airports in Mexico and two international airports in Jamaica. The company's segment includes Guadalajara, Tijuana, Puerto Vallarta, San Jose del Cabo, Montego Bay, Hermosillo, and Guanajuato airports. It generates the maximum revenue from the Guadalajara segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.